Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2014
02/06/2014WO2014020599A1 Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
02/06/2014WO2014020291A2 Mutant strains of neospora and uses thereof
02/06/2014WO2014020218A1 Vaccine against infestations caused by blood-sucking arthropods
02/06/2014WO2014020184A1 Means for treating heart disease
02/06/2014WO2014020149A1 Adeno-associated viral (aav) vectors useful for trasducing adipose tissue
02/06/2014WO2014020137A1 Recombinase mediated targeted dna enrichment for next generation sequencing
02/06/2014WO2014020069A1 Method for producing monomeric and multimeric molecules and uses thereof
02/06/2014WO2014020056A1 METHOD FOR PRODUCING SOLUBLE FcR AS Fc-FUSION WITH INERT IMMUNOGLOBULIN Fc-REGION AND USES THEREOF
02/06/2014WO2014019990A1 Production of infectious influenza viruses
02/06/2014WO2014019928A1 Tandem chromatin affinity purification in plant cell suspension cultures for identification of transcription factor target genes
02/06/2014WO2014019527A1 Prokaryotic bacterium photoinduced gene expression system and method for regulating and controlling gene expression by using same
02/06/2014WO2014019520A1 Tumor vessel specific binding polypeptide and application thereof
02/06/2014WO2014019408A1 Biomarkers for diabetes and usages thereof
02/06/2014WO2014019220A1 Method
02/06/2014WO2014019108A1 Nmnat1 mutant gene, primers, kit, and method for detecting same and use thereof
02/06/2014WO2014019028A1 Polysaccharide synthases (x)
02/06/2014WO2014019025A1 Epcam aptamer for detection of cancer stem cells
02/06/2014WO2013180767A3 Spider silk dragline polyucleotides, poltypeptides and methods of use thereof
02/06/2014WO2013176738A9 High-purity steviol glycosides
02/06/2014WO2013004076A8 Agr2 blocking antibody and use thereof
02/06/2014US20140041083 Stacked herbicide tolerance event 8264.44.06.1, related transgenic soybean lines, and detection thereof
02/06/2014US20140041082 Manipulation of Ammonium Transporters (AMTs) to Improve NUE in Higher Plants
02/06/2014US20140041081 Maize genes for controlling plant growth and organ size and their use in improving crop plants
02/06/2014US20140041080 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof
02/06/2014US20140041079 Genetically modified reduced-browning fruit-producing plant and produced fruit thereof, and method of obtaining such
02/06/2014US20140041077 Genetic Loci Associated with Fusarium Solani Tolerance in Soybean
02/06/2014US20140041076 Metabolic engineering of plants for increased homogentisate and tocochromanol production
02/06/2014US20140041075 Soybean transgenic event mon 87708 and methods of use thereof
02/06/2014US20140041073 Trait improvement in plants expressing myb-related proteins
02/06/2014US20140041072 Cloning and exploitation of a functional r-gene from solanum x edinense
02/06/2014US20140041068 Methods of Modifying Eukaryotic Cells
02/06/2014US20140039176 Methods and kits for extraction of dna
02/06/2014US20140039042 Bispecific aptamers mediating tumour cell lysis
02/06/2014US20140039038 Multi-conjugate of sirna and preparing method thereof
02/06/2014US20140039037 Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansions
02/06/2014US20140039035 Compositions and methods for treating obesity
02/06/2014US20140038902 Method of Treating Metastatic Cancer
02/06/2014US20140038848 Engineered microorganisms having resistance to ionic liquids
02/06/2014US20140038842 Cell surface display using pdz domains
02/06/2014US20140038831 High throughput yeast two-hybrid screening method and reagent kit
02/06/2014US20140038297 Genes and Proteins for the Biosynthesis of the Lantibiotic 107891
02/06/2014US20140038296 Metabolic engineering of microbial organisms
02/06/2014US20140038295 Biliverdin from a non-animal source
02/06/2014US20140038293 Methods for the production of ips cells using non-viral approach
02/06/2014US20140038292 Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME
02/06/2014US20140038291 Methods for reprogramming cells and uses thereof
02/06/2014US20140038286 Codon optimized sodium-iodide symporter gene and its use
02/06/2014US20140038284 Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
02/06/2014US20140038281 System for cargo delivery into the cells
02/06/2014US20140038272 Thermal cycling system and method of use
02/06/2014US20140038268 Activity of Fe-S Cluster Requiring Proteins
02/06/2014US20140038253 Compositions and methods for increased ethanol production from biomass
02/06/2014US20140038238 Nucleic acid amplification methods
02/06/2014US20140038237 Nucleic acid modifying enzymes
02/06/2014US20140038235 Methods For Producing Hyaluronan In A Recombinant Host Cell
02/06/2014US20140038233 Expression vector for animal cells
02/06/2014US20140038188 Methods and compositions for amplification of rna sequences
02/06/2014US20140038187 Thermus thermophilus nucleic acid polymerases
02/06/2014US20140037768 Methods and Compositions for Treating Keratin Hyperproliferation Disorders
02/06/2014US20140037717 Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1
02/06/2014US20140037714 Amino acid lipids and uses thereof
02/06/2014US20140037668 Combination neisserial compositions
02/06/2014US20140037660 Complexes of rna and cationic peptides for transfection and for immunostimulation
02/06/2014US20140037653 Modulation of lrch4 activity and therapeutic application thereof
02/06/2014US20140037652 Detection and Treatment of Polycystic Kidney Disease
02/06/2014US20140037644 Prospective Identification and Characterization of Breast Cancer Stem Cells
02/06/2014US20140037635 Methods of treatment using il-17e antagonists
02/06/2014US20140037616 Immunoglobulin 1
02/06/2014US20140037611 Treatment of Pompe's Disease
02/06/2014US20140037585 AAV8 Vector with Enhanced Functional Activity and Methods of Use Thereof
02/06/2014DE102012213492A1 Verfahren zur biotechnologischen Herstellung von Dihydrochalkonen Process for the biotechnological production of Dihydrochalkonen
02/06/2014CA2876099A1 Method for producing monomeric and multimeric molecules and uses thereof
02/06/2014CA2876096A1 Method for producing soluble fcr as fc-fusion with inert immunoglobulin fc-region and uses thereof
02/05/2014EP2692868A1 Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
02/05/2014EP2692867A2 Expression vector for animal cells
02/05/2014EP2692866A1 Genetic engineering method and material for increasing plant yield
02/05/2014EP2692865A1 Transposition-mediated identification of specific binding or functional proteins
02/05/2014EP2692864A1 Vector for foreign gene introduction and method for producing vector to which foreign gene has been introduced
02/05/2014EP2692863A1 Sample nucleic acid for single nucleotide polymorphism detection purposes, pcr primer for preparing sample for single nucleotide polymorphism detection purposes, and method for preparing sample for single nucleotide polymorphism detection purposes which can be used in ion exchange chromatographic analysis
02/05/2014EP2692862A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
02/05/2014EP2692861A1 Nucleic acid construct containing nucleic acid derived from genotype 1b hcv genome, hcv genome-replicating cells transfected with same, and method for producing infectious hcv particles
02/05/2014EP2692860A1 Regulator of anaplastic state and applications therefor
02/05/2014EP2692859A1 Method for producing cardiomyocyte sheet from embryonic stem cells
02/05/2014EP2692853A1 Membrane-separation-type culture device, membrane-separation-type culture kit, stem cell separation method using same, and separation membrane
02/05/2014EP2692737A1 Fully human anti-vap-1 monoclonal antibodies
02/05/2014EP2692736A1 BSA-specific antibodies
02/05/2014EP2692733A1 Nucleic acids encoding soluble forms of CD83
02/05/2014EP2692731A1 Recombinant Adeno-Associated virus (AAV) vector particles displaying high-affinity ligands for cell-type specific gene delivery
02/05/2014EP2692354A1 Means for treating heart disease
02/05/2014EP2692352A1 Hot flash suppressant
02/05/2014EP2691548A2 Microrna 130a,b as a tumor suppressor and sensitizing agent for chemotherapy
02/05/2014EP2691543A2 Detection of target nucleic acid sequence by pto cleavage and extension-dependent cleavage
02/05/2014EP2691542A1 Screening methods for identifying specific staphylococcus aureus inhibitors
02/05/2014EP2691530A2 Cmv glycoproteins and recombinant vectors
02/05/2014EP2691529A1 Methods and compositions for treating brain diseases
02/05/2014EP2691528A1 Cotton transgenic event mon 88701 and methods of use thereof
02/05/2014EP2691527A1 Aptamers that are specific for immunoglobulin-binding cell wall proteins
02/05/2014EP2691526A1 Compositions and methods for treating, diagnosing and monitoring disease
02/05/2014EP2691525A1 Treatment and prognosis of solid tumour cancers
02/05/2014EP2691524A1 Stacking nucleic acid and methods for use thereof